Cell signaling and cancer
Publication type: Journal Article
Publication date: 2003-09-01
scimago Q1
wos Q1
SJR: 19.027
CiteScore: 57.7
Impact factor: 44.5
ISSN: 15356108, 18783686
PubMed ID:
14522250
Cancer Research
Oncology
Cell Biology
Abstract
During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. Many of the proteins currently under investigation as possible targets for cancer therapy are signaling proteins that are components of these pathways. The nature of these signaling pathways and their roles in tumorigenesis were the subject of a recent Beatson International Cancer Conference.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Cancer Research
5 publications, 2.22%
|
|
|
Oncology Reports
4 publications, 1.78%
|
|
|
International Journal of Molecular Sciences
4 publications, 1.78%
|
|
|
Oncogene
4 publications, 1.78%
|
|
|
PLoS ONE
4 publications, 1.78%
|
|
|
Mini-Reviews in Medicinal Chemistry
3 publications, 1.33%
|
|
|
Molecular Medicine Reports
3 publications, 1.33%
|
|
|
Molecules
3 publications, 1.33%
|
|
|
Scientific Reports
3 publications, 1.33%
|
|
|
Life Sciences
3 publications, 1.33%
|
|
|
International Journal of Biochemistry and Cell Biology
3 publications, 1.33%
|
|
|
Biochemical and Biophysical Research Communications
3 publications, 1.33%
|
|
|
Phytotherapy Research
3 publications, 1.33%
|
|
|
Current Pharmaceutical Design
2 publications, 0.89%
|
|
|
Journal of Cell Science
2 publications, 0.89%
|
|
|
International Journal of Oncology
2 publications, 0.89%
|
|
|
Sensors
2 publications, 0.89%
|
|
|
Nutrients
2 publications, 0.89%
|
|
|
Frontiers in Pharmacology
2 publications, 0.89%
|
|
|
Frontiers in Oncology
2 publications, 0.89%
|
|
|
Medical Oncology
2 publications, 0.89%
|
|
|
Tumor Biology
2 publications, 0.89%
|
|
|
BMC Cancer
2 publications, 0.89%
|
|
|
Cancer Cell International
2 publications, 0.89%
|
|
|
Biomedicine and Pharmacotherapy
2 publications, 0.89%
|
|
|
Journal of Neuroscience Methods
2 publications, 0.89%
|
|
|
Pathology Research and Practice
2 publications, 0.89%
|
|
|
FEBS Letters
2 publications, 0.89%
|
|
|
Cell Biology International
2 publications, 0.89%
|
|
|
1
2
3
4
5
|
Publishers
|
10
20
30
40
50
60
|
|
|
Elsevier
55 publications, 24.44%
|
|
|
Springer Nature
44 publications, 19.56%
|
|
|
Wiley
25 publications, 11.11%
|
|
|
MDPI
17 publications, 7.56%
|
|
|
Spandidos Publications
9 publications, 4%
|
|
|
Frontiers Media S.A.
7 publications, 3.11%
|
|
|
Bentham Science Publishers Ltd.
6 publications, 2.67%
|
|
|
American Association for Cancer Research (AACR)
6 publications, 2.67%
|
|
|
Public Library of Science (PLoS)
5 publications, 2.22%
|
|
|
American Chemical Society (ACS)
5 publications, 2.22%
|
|
|
SAGE
4 publications, 1.78%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 1.78%
|
|
|
Royal Society of Chemistry (RSC)
3 publications, 1.33%
|
|
|
Taylor & Francis
3 publications, 1.33%
|
|
|
Oxford University Press
3 publications, 1.33%
|
|
|
Hindawi Limited
3 publications, 1.33%
|
|
|
The Company of Biologists
2 publications, 0.89%
|
|
|
Mary Ann Liebert
2 publications, 0.89%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 0.89%
|
|
|
Rockefeller University Press
2 publications, 0.89%
|
|
|
American Society for Clinical Investigation
1 publication, 0.44%
|
|
|
Impact Journals
1 publication, 0.44%
|
|
|
Portland Press
1 publication, 0.44%
|
|
|
Pharmaceutical Society of Korea
1 publication, 0.44%
|
|
|
Pleiades Publishing
1 publication, 0.44%
|
|
|
Meditsinski Universitet - Sofia
1 publication, 0.44%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.44%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.44%
|
|
|
Association for Computing Machinery (ACM)
1 publication, 0.44%
|
|
|
10
20
30
40
50
60
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
225
Total citations:
225
Citations from 2025:
8
(3.56%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/S1535-6108(03)00216-2
UR - https://doi.org/10.1016/S1535-6108(03)00216-2
TI - Cell signaling and cancer
T2 - Cancer Cell
AU - Martin, G. Steven
PY - 2003
DA - 2003/09/01
PB - Elsevier
SP - 167-174
IS - 3
VL - 4
PMID - 14522250
SN - 1535-6108
SN - 1878-3686
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2003_Martin,
author = {G. Steven Martin},
title = {Cell signaling and cancer},
journal = {Cancer Cell},
year = {2003},
volume = {4},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016/S1535-6108(03)00216-2},
number = {3},
pages = {167--174},
doi = {10.1016/S1535-6108(03)00216-2}
}
Cite this
MLA
Copy
Martin, G. Steven. “Cell signaling and cancer.” Cancer Cell, vol. 4, no. 3, Sep. 2003, pp. 167-174. https://doi.org/10.1016/S1535-6108(03)00216-2.